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Primary non-adherence was defined as a binary outcome representing failure to 
fill a new prescription within 30 days after the medication was prescribed to the 
patient and secondary non-adherence was defined as a number of refills obtained 
by a patient within a 12 month follow up period. Various measured patient, pre-
scription, and prescribing physician characteristics were included in the model. 
Hurdle model results indicate that important predictors are missing from the 
single-component models, but exist in the joint model of primary and secondary 
non-adherence. ConClusions: The authors conclude that a hurdle modeling 
approach enables the taking of simple, well-understood models primary (logistic 
regression) and secondary non-adherence (count regression) and combine them 
in a way that provides a better description of the data than a single-component 
models provide separately.
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objeCtives: The main objective of this study is to explore the perception of doc-
tors regarding quality of pharmaceutical care services in Khyber Pakhtunkhwa, 
Pakistan. Methods: A qualitative study design was adopted. A semi-structured 
interview guide was developed, through snowball sampling technique face to face 
interviews were conducted until saturation point has reached till 15th doctors. 
Doctors from public and private hospitals in Khyber Pakhtunkhwa, Pakistan who 
were interviewed from December to February 2014. The interviews were conducted 
at the doctor’s work-place. Written consent was obtained from the participants 
prior to the interview. Results: Among the respondents interviewed, nine were 
male and six female doctors. Thematic content analysis yielded 4 major themes: (a) 
Collaboration of doctors and pharmacists, (b) Lack of provision of patient counseling, 
(c) Separation of prescribing & counseling services, (d) Patient compliance through 
pharmaceutical care. ConClusions: The findings demonstrated that implementa-
tion of pharmaceutical care provision would benefit the doctors and patient. Doctors 
were willing to collaborate with pharmacist because it will facilitate the doctors as 
due to time limit they are unable to do proper patient counseling. They have also 
showed positive response towards implementation of pharmacy practice which 
would definitely improve the patient compliance.
PIH18
reference vAlue of blooD serum AlKAlIne PHosPHAtAse In mongolIAn 
ADult
Chanagsuren G.1, Dorj E.2, Dorj O.1, Gunchin B.3
1School of Nursing, HSUM, Ulaanbaatar, Mongolia, 2School of Biomedicine, HSUM, Ulaanbaatar, 
Mongolia, 3Health Sciences University of Mongolia, Ulaanbaatar, Mongolia
objeCtives: To determine the reference value of blood serum alkaline phos-
phatase of adult according to related age, sex, season and region. Methods: In 
the research, totally 3742 people were conducted. The research was implemented 
and supported by central laboratory of Biomedical school, HSUM, “Mobio” labora-
tory of Korea and “Mega” laboratory. The research of serum alkaline phosphatase 
was made by the kinetic method which is confirmed by IFCC and used the liquid 
reagent of Roche Hospitex diagnostics and Human firm. The research result was 
statistically analyzed with standard programming the SPSS statistic. Results: 
The mean value of blood serum alkaline phosphatase activity of adult with con-
fidence interval P = 0.95, the mean value was for the male 81.78±0.48, (n= 1597) 
U/L and for female 76.99±0.41 (n= 2145) U/L. While determining the Interval for 
reference value of blood serum alkaline phosphatase, interval was for male 51.08-
112.47 U/L8 U/L and for female 39.77-114.21U/L. Blood serum alkaline phosphatase 
activity of adult Mongolian have dependence of sex (p< 0.0001) and it was high 
for male. Also, serum alkaline phosphatase activity is varying (p< 0.0001, r= 0.102) 
depending on age. There is no dependence of activity of serum (p= 0.43) appeared 
by region. ConClusions: Mean value of serum alkaline phosphatase activity is 
for people 70.50±0.63 U/L and minimum limit of reference value is 40.09-116.72U/L.
The activity of serum alkaline phosphatase has deference from age and sex 
with confidence interval (p= 0.0001). For male high, for female low, weak direct 
dependence from age (r= 0.102) and strong direct dependence from sex were dis-
covered.
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objeCtives: Utility data are essential for cost-effectiveness analyses, especially 
with the introduction of HTA in Japan in 2016. Given a paucity of information regard-
ing the availability of data and related research methodologies used in Japan, this 
study aims to present a comprehensive literature review regarding utility assess-
ment in Japan. Methods: Medline (English) and Ichushi (Japanese) were searched 
to understand where the utilities were derived. Search terms included Utility OR 
health state preference OR 効用値 OR QALY OR 質調整生存年 [Title/Abstract] and all 
articles published before November 30, 2013 were reviewed. Articles were required 
to detail the methods for utility development or selection, and needed to be based 
in Japan. They were also required to focus on the assessment of utilities or be part 
of a cost-effectiveness analysis. Results: A total of 246 manuscripts were found 
after removing duplicates. From these, 137 were included in the full text review and 
99 were selected for analysis. The number of studies increased from 1 manuscript in 
2000 to a total of 16 in 2012 and 6 in 2013. 70 articles were cost-effectiveness analysis. 
50 articles cited utility values from previous or overseas studies. Among original util-
ity measurement studies EQ-5D and TTO were the most frequently used methods. 
the first and second strategies, respectively, which were much lower than the 2013 
Indonesian Gross Domestic Product (GDP) per capita of US$ 4,790. ConClusions: 
The implementation of a birth-dose rotavirusvaccination strategy in Indonesia 
would be more cost-effective than a later vaccination schedule. The mortality 
rate and vaccine price were the most influential parameters impacting the cost-
effectiveness results.
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objeCtives: Since 2000, when the PCV7 (7-valent Pneumococcal Conjugate Vaccine) 
gradually went public, lots of cost-effectiveness evaluations on it have been done 
in Euro-American countries. In contrast, there is little economic review on PCV7 in 
Asian-Pacific region. This review comprehensively evaluated the cost and benefit 
of introducing PCV7 into the national immunization plan (evaluation include with 
and without the herd effect) of the Asia-Pacific region, to serve as a policy reference 
for the Asian-Pacific regions in their immunization plans. Methods: All articles 
were identified from PubMed and Embase database between January 1st, 2002 and 
June 30th, 2013 in Korea, Hong Kong, Malaysia, Singapore, Australia and Japan. The 
following keywords were used: cost, cost-effectiveness, pneumococcal diseases 
and pneumococcal conjugate vaccine. Results were collected in terms of different 
assumptions, such as incidence ratios, vaccine uptake rate, and duration of protec-
tion and so on. Costs included both direct and indirect cost. Results: The clinical 
benefits and cost effective results varied from country to country. For illnesses 
avoided, the results varied between 4,030 and 30,040 per year. In terms of deaths 
avoided, the number of events varied between 14.2 and 643 per year. Studies that 
considered herd effects reported much more favorable cost-effectiveness than those 
that did not, with the ICERs U$5,929/LYG in Hong Kong, U$10,261/LYG in Malaysia, 
U$43,275/QALY in Singapore from social perspective. ConClusions: With respect 
to the WHO’s classification that an intervention is cost-effective if ICER is between 1 
And 3 times of GDP, universal PCV7 vaccination would be considered cost-effective 
in Hong Kong, Malaysia and Singapore.
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objeCtives: To determine the impact of partial reimbursement on antivirals which 
was first implemented in July 1, 2011 on antiviral utilization and compliance for CHB 
patients in Beijing. Methods: Two separate cohorts were enrolled. These consisted 
14,163 CHB outpatients who were referred to Beijing You’an Hospital during Jan 1, 
2010 to Dec 30, 2010 and 16,228 between Jul 1, 2011 and Jun 30, 2012. Follow-up ended 
on Jun 30, 2011 and Dec 31, 2012, respectively. Demographic characteristics, routine 
biochemical and virological detection results, and antiviral prescription informa-
tion were collected from electronic database. Antiviral utilization, medication pos-
session ratio (MPR) and persistence rate were compared between patients with 
medical insurance (PMI) and paid out-of-pocket (PPO). Questionnaire survey was 
given to randomly sample 307 outpatients to confirm the validity of the electronic 
database. Results: A total of 13,364 outpatients from each cohort were enrolled 
after propensity score matching. The antiviral utilization rate for PMI increased 
from 57.4 to 75.9% (P< 0.001) after the reimbursement policy and the rate among PPO 
increased from 54.9 to 56.7% (P= 0.028). A 5% increase (83.4%±24.3 vs. 88.7%±19.4%, 
P< 0.0001) in MPR was observed among PMI after reimbursement and an increase of 
under 2% was observed among PPO (83.7±24.2 vs. 85.2±23.1%, P= 0.0055). About 71% 
of the patients had more than 80% MPR in each cohort before reimbursement. This 
increased to 79.3% (P< 0.0001) and 73.0% (P= 0.0228) for PMI and PPO, respectively. PMI 
had a higher 6-, 12-, 15-month persistence rate than PPO, especially for outpatients 
receiving ETV and ADV. The questionnaire with 100% respond rate showed that more 
than 90% outpatients only took antiviral medicine at You’an Hospital, suggesting the 
validity of the electronic database. ConClusions: The new reimbursement policy 
showed a positive impact on antivirals utilization as well as compliance for insured 
CHB patients, especially for patients receiving ETV and ADV.
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objeCtives: Medication non-adherence to chronic therapies may severely impact 
effectiveness of treatment. Non-adherence may occur at different stages in a 
patient’s treatment journey. It may occur at the very beginning of therapy if a 
patient receives the initial prescription but does not redeem it at a pharmacy 
(primary non-adherence), or it may happen after the patient fills a prescription 
at a pharmacy but fails to follow the instructions or fails to refill the prescription 
(secondary non-adherence). Methods: The purpose of this study is to demon-
strate that both primary and secondary non-adherences can be jointly described 
by a hurdle model, which has the interpretation as a two-part model. The first 
part is a binary outcome model, and the second part is a truncated count model 
(Poisson or negative binomial). The hurdle model is an example of the finite mix-
ture models which can be fitted by SAS’s new procedure PROC FMM. Results: 
Data in this retrospective cohort study of medication non-adherence was obtained 
from blind computerized pharmacy records of a national retail pharmacy chain. 
